BIZENGRI
- Product NDC
- 71837-1000
- 11-digit product format
- 718371000
- Labeler code
- 71837
- Product ID
- 71837-1000_777005ee-d019-4976-abb4-b998cf68e05f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Zenocutuzumab
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Partner Therapeutics, Inc.
- Application
- BLA761352
- Marketing category
- BLA
- Marketing start
- 2024-12-04
- Substance
- ZENOCUTUZUMAB
- Active strength
- 20 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- BIZENGRI
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ZENOCUTUZUMAB | 20 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | AE72RB1W1X |
| Rxcui | 2699594, 2699601 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71837-1000-1 | BIZENGRI | 18.75 mL in 1 VIAL, GLASS | INJECTION | 18.75 | | 3 |
| 71837-1000-2 | BIZENGRI | 2 in 1 CARTON | INJECTION | 2 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71837-1000 | BIZENGRI (ZENOCUTUZUMAB) INJECTION [PARTNER THERAPEUTICS, INC.] | 2 | Current NDC, 2 package rows | 20250309_203daea4-fc87-40a4-a92f-ba2351b16de1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71837-1000-1 | 71837100001 | 18.75 mL in 1 VIAL, GLASS | 18.75 ml | | | | Historical |
| 71837-1000-2 | 71837100002 | 2 VIAL, GLASS in 1 CARTON (71837-1000-2) / 18.75 mL in 1 VIAL, GLASS (71837-1000-1) | | 2024-12-16 | No | No | Current |